期刊
MOLECULAR AND CELLULAR BIOCHEMISTRY
卷 368, 期 1-2, 页码 195-201出版社
SPRINGER
DOI: 10.1007/s11010-012-1360-5
关键词
Cancer; Interferon-stimulated gene15; Tumor necrosis factor-alpha; Type I interferon
类别
资金
- Thailand Research Fund, Faculty of Dentistry, Mahidol University [MRG5180019]
- Faculty of Medicine Research Fund, Chiang Mai University, Thailand
Interferon-stimulated gene15 (ISG15) is the first characterized ubiquitin-like protein, which is strongly induced by type I interferons (IFN-alpha/beta), bacterial endotoxin, and cellular stress. Up-regulation of ISG15 is observed in several cancer cell types and is associated with cancer progression. As many cytokines can influence all stages of tumorigenesis, the elevated expression of ISG15 system may be regulated in cancer cells by inflammatory cytokines. In this study, we showed that TNF-alpha, but not TGF-beta and IL-6, up-regulates levels of both ISG15 and its conjugates in human lung carcinoma A549 and human squamous carcinoma HSC4 cell lines. Induction of ISG15 and its conjugates by TNF-alpha was dose-dependent and required mediation of p38 MAP kinase and Jak1 through up-regulation of endogenous type I interferon expression. SB202190 (p38 MAPK inhibitor) and Jak1 inhibitor suppressed TNF-alpha-induced expression of ISG15 and its conjugates. However, only SB202190 inhibited the expression of type I interferons by TNF-alpha. Although B18R, a soluble type I interferon receptor, totally abolished the effect of exogenous IFN-beta, it was unable to inhibit completely the TNF-alpha-induced ISG15 production. In addition, the initiation of ISG15 induction by TNF-alpha was detected earlier than that of IFN-beta induction. Taken together, TNF-alpha elicits the induction of ISG15 and ISG15 conjugates not only via the autocrine stimulation of type I interferon expression, but also through a type I interferon-independent pathway. These data provide a possible link between inflammatory response and cancer progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据